Skip to main content
TipRanks
Go Ultimate75% OFF

Nektar Therapeutics (NKTR) Stock Forecast & Price Target

1,673 Followers
See the Price Targets and Ratings of:

NKTR Analyst Ratings

Strong Buy
13Ratings
10Buy3Hold0Sell
Based on 13 analysts giving stock ratings to Nektar Therapeutics in the past 3 months

NKTR Stock 12 Month Forecast

$138.00▲(356.95% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Nektar Therapeutics in the last 3 months. The average price target is $138.00 with a high forecast of $192.00 and a low forecast of $40.00. The average price target represents a 356.95% change from the last price of $30.20.
Highest Price Target$192.00Average Price Target$138.00Lowest Price Target$40.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NKTR
Price TargetArticle
H.C. Wainwright$185buy512.58%UpsideReiterated11/16/26
Canaccord Genuity$153→$149buy393.38%UpsideReiterated11/16/26
Oppenheimer Analyst forecast on NKTRUnknown AnalystNot RankedOppenheimer$140buy363.58%UpsideReiterated11/13/26
Piper Sandler$192buy535.76%UpsideReiterated11/13/26
Wedbush$50→$40hold32.45%UpsideReiterated11/13/26
Leerink Partners$130buy330.46%UpsideReiterated11/13/26
UBS$53hold75.50%UpsideInitiated10/11/26
BTIG$178buy489.40%UpsideReiterated10/09/26
Raymond James―hold―Initiated10/08/26
Citi$151buy400.00%UpsideReiterated10/05/26
B. Riley Securities Analyst forecast on NKTRUnknown AnalystNot RankedB. Riley Securities$150buy396.69%UpsideReiterated10/02/26
William Blair―buy―Reiterated10/01/26
Jefferies$150buy396.69%UpsideReiterated10/01/26
J.P. Morgan$65hold115.23%UpsideInitiated08/21/26
TD Cowen―buy―Reiterated08/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PVLAPalvella Therapeutics
IRLAIRulya Therapeutics
RZLTRezolute
PTGXProtagonist Therapeutics
CTMXCytomX Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Nektar Therapeutics

3 Months
Arthur He CFA
Arthur He CFAH.C. Wainwright
Success Rate8/20 ratings generated profit
40%
Average Return
+25.36%

Copying Arthur He CFA's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of +25.36% per trade.

1 Year
Yasmeen Rahimi
Yasmeen RahimiPiper Sandler
Success Rate8/16 ratings generated profit
50%
Average Return
+140.24%

Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +140.24% per trade.

2 Years
Yasmeen Rahimi
Yasmeen RahimiPiper Sandler
Success Rate7/16 ratings generated profit
44%
Average Return
+33.65%

Copying Yasmeen Rahimi's trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of +33.65% per trade.

NKTR Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NKTR
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy911151816
Buy22231
Hold12354
Sell00000
Strong Sell00000
total1215202621

In the current month, NKTR has received 17 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. NKTR average Analyst price target in the past 3 months is 138.00.

NKTR Financial Forecast

$-5$-4$-3$-2$-1Q1 2026Q3 2026Q4 2026
High$-1.70
Consensus$-2.47
Low$-3.50

NKTR Earnings Forecast

Next quarter’s earnings estimate for NKTR is -$2.47 with a range of -$3.50 to -$1.70. The previous quarter’s EPS was -$1.63. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$7.6M$11.2M$14.7M$18.3M$21.8MQ1 2026Q3 2026Q4 2026
High$12M
Consensus$9.22M
Low$7.6M

NKTR Sales Forecast

Next quarter’s sales forecast for NKTR is $9.22M with a range of $7.60M to $12.00M. The previous quarter’s sales results were $9.39M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NKTR Stock Forecast FAQ

What is NKTR’s average 12-month price target, according to analysts?
Based on analyst ratings, Nektar Therapeutics’s 12-month average price target is $138.00.
What is NKTR’s upside potential, based on the analysts’ average price target?
Nektar Therapeutics has 356.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NKTR a Buy, Sell or Hold?
Nektar Therapeutics has a consensus rating of Strong Buy which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.
What is Nektar Therapeutics’s price target?
The average price target for Nektar Therapeutics is $138.00. This is based on 13 12-month price targets, issued in the past 3 months. The highest analyst price target is $192.00, the lowest forecast is $40.00. The average price target represents a 356.95% increase from the current price of $30.2.
What do analysts say about Nektar Therapeutics?
Nektar Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Street analysts.
How can I buy shares of NKTR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.